Literature DB >> 27561002

Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology.

Angela K Green1, William A Wood1, Ethan M Basch2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27561002     DOI: 10.1001/jama.2016.12770

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Evidence Underlying Recommendations and Payments from Industry to Authors of the National Comprehensive Cancer Network Guidelines.

Authors:  Xu Liu; Ling-Long Tang; Yan-Ping Mao; Qing Liu; Ying Sun; Lei Chen; Jin-Ching Lin; Jun Ma
Journal:  Oncologist       Date:  2018-11-20

2.  Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.

Authors:  Aaron P Mitchell; Akriti Mishra; Pranam Dey; Michael A Curry; Niti U Trivedi; Michael Haddadin; Mohammed W Rahman; Aaron N Winn; Stacie B Dusetzina; Peter B Bach
Journal:  Oncologist       Date:  2021-05-26

3.  Frequency and level of evidence used in recommendations by the National Comprehensive Cancer Network guidelines beyond approvals of the US Food and Drug Administration: retrospective observational study.

Authors:  Jeffrey Wagner; John Marquart; Julia Ruby; Austin Lammers; Sham Mailankody; Victoria Kaestner; Vinay Prasad
Journal:  BMJ       Date:  2018-03-07

4.  Affordability of oncology drugs: accuracy of budget impact estimations.

Authors:  Joost W Geenen; Mark Jut; Cornelis Boersma; Olaf H Klungel; Anke M Hövels
Journal:  J Mark Access Health Policy       Date:  2019-11-30

5.  Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study.

Authors:  Magd Ahmed Kotb; Dalia Mosallam; Christine William Shaker Basanti; Sally Talaat Mostafa El Sorogy; Ahmed M Badr; Hend El Hosainy Abd El Baky; Iman Hassan Draz
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.